The Hindu: Published on December 04, 2024:
Why in News?
The Karnataka government has sought action against Paschim Banga Pharmaceuticals, the manufacturer of Compound Sodium Lactate Injection I.P (Ringer’s Lactate), following recent maternal deaths in Ballari District Hospital. The state has requested the Drugs Controller General of India (DCGI) to investigate the Standard Quality certification issued to the company.
Background: Between November 9 and 11, 2023, four maternal deaths occurred at Ballari District Hospital following caesarean sections. The women were administered Ringer’s Lactate, supplied by Paschim Banga Pharmaceuticals. The hospital had conducted 34 such operations during those days, and seven of them faced complications, with four women unfortunately passing away.
Key Developments:
Implications:
Conclusion: The Karnataka government's request for action highlights concerns over the quality of medical supplies in hospitals. The ongoing investigation will play a crucial role in determining the cause of the maternal deaths and in safeguarding the health of patients in the future.